245 related articles for article (PubMed ID: 34276354)
1. Computational Drug Repurposing for Alzheimer's Disease Using Risk Genes From GWAS and Single-Cell RNA Sequencing Studies.
Xu Y; Kong J; Hu P
Front Pharmacol; 2021; 12():617537. PubMed ID: 34276354
[No Abstract] [Full Text] [Related]
2. Identifying candidate genes and drug targets for Alzheimer's disease by an integrative network approach using genetic and brain region-specific proteomic data.
Liu A; Manuel AM; Dai Y; Fernandes BS; Enduru N; Jia P; Zhao Z
Hum Mol Genet; 2022 Sep; 31(19):3341-3354. PubMed ID: 35640139
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer's Disease: Using the Multiomics Approach.
Advani D; Kumar P
ACS Omega; 2021 Jun; 6(21):13870-13887. PubMed ID: 34095679
[TBL] [Abstract][Full Text] [Related]
4. Genetics of Alzheimer's disease.
Chouraki V; Seshadri S
Adv Genet; 2014; 87():245-94. PubMed ID: 25311924
[TBL] [Abstract][Full Text] [Related]
5. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
6. Association of GWAS-linked loci with late-onset Alzheimer's disease in a northern Han Chinese population.
Tan L; Yu JT; Zhang W; Wu ZC; Zhang Q; Liu QY; Wang W; Wang HF; Ma XY; Cui WZ
Alzheimers Dement; 2013 Sep; 9(5):546-53. PubMed ID: 23232270
[TBL] [Abstract][Full Text] [Related]
7. Genetics of Alzheimer's Disease.
Kim JH
Dement Neurocogn Disord; 2018 Dec; 17(4):131-136. PubMed ID: 30906402
[TBL] [Abstract][Full Text] [Related]
8. Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease.
Fang J; Zhang P; Wang Q; Chiang CW; Zhou Y; Hou Y; Xu J; Chen R; Zhang B; Lewis SJ; Leverenz JB; Pieper AA; Li B; Li L; Cummings J; Cheng F
Alzheimers Res Ther; 2022 Jan; 14(1):7. PubMed ID: 35012639
[TBL] [Abstract][Full Text] [Related]
9. Unraveling the intercellular communication disruption and key pathways in Alzheimer's disease: an integrative study of single-nucleus transcriptomes and genetic association.
Liu A; Fernandes BS; Citu C; Zhao Z
Alzheimers Res Ther; 2024 Jan; 16(1):3. PubMed ID: 38167548
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide association study of Alzheimer's disease.
Kamboh MI; Demirci FY; Wang X; Minster RL; Carrasquillo MM; Pankratz VS; Younkin SG; Saykin AJ; ; Jun G; Baldwin C; Logue MW; Buros J; Farrer L; Pericak-Vance MA; Haines JL; Sweet RA; Ganguli M; Feingold E; Dekosky ST; Lopez OL; Barmada MM
Transl Psychiatry; 2012 May; 2(5):e117. PubMed ID: 22832961
[TBL] [Abstract][Full Text] [Related]
11. Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood.
Bourdakou MM; Fernández-Ginés R; Cuadrado A; Spyrou GM
Redox Biol; 2023 Nov; 67():102881. PubMed ID: 37696195
[TBL] [Abstract][Full Text] [Related]
12. Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains.
Karch CM; Jeng AT; Nowotny P; Cady J; Cruchaga C; Goate AM
PLoS One; 2012; 7(11):e50976. PubMed ID: 23226438
[TBL] [Abstract][Full Text] [Related]
13. The Alzheimer's Cell Atlas (TACA): A single-cell molecular map for translational therapeutics accelerator in Alzheimer's disease.
Zhou Y; Xu J; Hou Y; Bekris L; Leverenz JB; Pieper AA; Cummings J; Cheng F
Alzheimers Dement (N Y); 2022; 8(1):e12350. PubMed ID: 36254161
[TBL] [Abstract][Full Text] [Related]
14. Functional insight into LOAD-associated microglial response genes.
Jonas LA; Jain T; Li YM
Open Biol; 2022 Jan; 12(1):210280. PubMed ID: 35078351
[TBL] [Abstract][Full Text] [Related]
15. ABCA7 p.G215S as potential protective factor for Alzheimer's disease.
Sassi C; Nalls MA; Ridge PG; Gibbs JR; Ding J; Lupton MK; Troakes C; Lunnon K; Al-Sarraj S; Brown KS; Medway C; Clement N; Lord J; Turton J; Bras J; Almeida MR; ; Holstege H; Louwersheimer E; van der Flier WM; Scheltens P; Van Swieten JC; Santana I; Oliveira C; Morgan K; Powell JF; Kauwe JS; Cruchaga C; Goate AM; Singleton AB; Guerreiro R; Hardy J
Neurobiol Aging; 2016 Oct; 46():235.e1-9. PubMed ID: 27289440
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the intercellular communication disruption and key pathways in Alzheimer's disease: An integrative study of single-nucleus transcriptomes and genetic association.
Liu A; Fernandes BS; Citu C; Zhao Z
Res Sq; 2023 Sep; ():. PubMed ID: 37790454
[TBL] [Abstract][Full Text] [Related]
17. Drug repurposing for Alzheimer's disease from 2012-2022-a 10-year literature review.
Grabowska ME; Huang A; Wen Z; Li B; Wei WQ
Front Pharmacol; 2023; 14():1257700. PubMed ID: 37745051
[No Abstract] [Full Text] [Related]
18. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
Zhang M; Schmitt-Ulms G; Sato C; Xi Z; Zhang Y; Zhou Y; St George-Hyslop P; Rogaeva E
PLoS One; 2016; 11(12):e0168812. PubMed ID: 28005991
[TBL] [Abstract][Full Text] [Related]
19. Network Proximity-based computational pipeline identifies drug candidates for different pathological stages of Alzheimer's disease.
Wu Q; Su S; Cai C; Xu L; Fan X; Ke H; Dai Z; Fang S; Zhuo Y; Wang Q; Pan H; Gu Y; Fang J
Comput Struct Biotechnol J; 2023; 21():1907-1920. PubMed ID: 36936813
[TBL] [Abstract][Full Text] [Related]
20. Whole-exome sequencing of the BDR cohort: evidence to support the role of the PILRA gene in Alzheimer's disease.
Patel T; Brookes KJ; Turton J; Chaudhury S; Guetta-Baranes T; Guerreiro R; Bras J; Hernandez D; Singleton A; Francis PT; Hardy J; Morgan K
Neuropathol Appl Neurobiol; 2018 Aug; 44(5):506-521. PubMed ID: 29181857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
